Canada - TSX:ACB - CA05156X8504 - Common Stock
The current stock price of ACB.CA is 7.34 CAD. In the past month the price increased by 6.69%. In the past year, price decreased by -10.92%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| BHC.CA | BAUSCH HEALTH COS INC | 1.64 | 3.22B | ||
| TLRY.CA | TILRAY BRANDS INC | N/A | 2.34B | ||
| CRON.CA | CRONOS GROUP INC | 50.57 | 1.36B | ||
| DHT-UN.CA | DRI HEALTHCARE TRUST | 7.05 | 836.13M | ||
| WEED.CA | CANOPY GROWTH CORP | N/A | 642.67M | ||
| DHT-U.CA | DRI HEALTHCARE TRUST | 4.98 | 591.08M | ||
| GUD.CA | KNIGHT THERAPEUTICS INC | N/A | 581.13M | ||
| TSND.CA | TERRASCEND CORP | N/A | 417.81M | ||
| HITI.CA | HIGH TIDE INC | N/A | 405.93M | ||
| CPH.CA | CIPHER PHARMACEUTICALS INC | 22.64 | 366.89M | ||
| OGI.CA | ORGANIGRAM GLOBAL INC | N/A | 331.80M | ||
| NGEN.CA | NERVGEN PHARMA CORP | N/A | 280.43M |
Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products. The company is headquartered in Leduc, Alberta and currently employs 1,101 full-time employees. The company went IPO on 2007-09-26. The Company’s principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally. The Company’s segments include Cannabis and Plant Propagation. The firm's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, IndiMed and CraftPlant. The firm also holds a 50.1% controlling interest in Bevo Farms Ltd., a supplier of propagated vegetables and ornamental plants in North America. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others.
AURORA CANNABIS INC
2207 90B Street Sw
Leduc ALBERTA T9E 0V6 CA
CEO: Miguel Martin
Employees: 1101
Phone: 16043625207
Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products. The company is headquartered in Leduc, Alberta and currently employs 1,101 full-time employees. The company went IPO on 2007-09-26. The Company’s principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally. The Company’s segments include Cannabis and Plant Propagation. The firm's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, IndiMed and CraftPlant. The firm also holds a 50.1% controlling interest in Bevo Farms Ltd., a supplier of propagated vegetables and ornamental plants in North America. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others.
The current stock price of ACB.CA is 7.34 CAD. The price increased by 3.23% in the last trading session.
ACB.CA does not pay a dividend.
ACB.CA has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
The Revenue of AURORA CANNABIS INC (ACB.CA) is expected to grow by 8.72% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
AURORA CANNABIS INC (ACB.CA) has a market capitalization of 412.88M CAD. This makes ACB.CA a Small Cap stock.
You can find the ownership structure of AURORA CANNABIS INC (ACB.CA) on the Ownership tab.
ChartMill assigns a technical rating of 2 / 10 to ACB.CA. When comparing the yearly performance of all stocks, ACB.CA is a bad performer in the overall market: 78.79% of all stocks are doing better.
ChartMill assigns a fundamental rating of 3 / 10 to ACB.CA. The financial health of ACB.CA is average, but there are quite some concerns on its profitability.
Over the last trailing twelve months ACB.CA reported a non-GAAP Earnings per Share(EPS) of -0.35. The EPS increased by 44.79% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -2.32% | ||
| ROE | -3.53% | ||
| Debt/Equity | 0.07 |
9 analysts have analysed ACB.CA and the average price target is 8.08 CAD. This implies a price increase of 10.13% is expected in the next year compared to the current price of 7.34.
For the next year, analysts expect an EPS growth of -288.53% and a revenue growth 8.72% for ACB.CA